Literature DB >> 4597719

Double-blind controlled comparison of phlebitis produced by cephapirin and cephalothin.

J Carrizosa, M E Levison, D Kaye.   

Abstract

In a double-blind study with each patient as his own control cephapirin and cephalothin were administered to 20 patients in opposite arms for a period of 48 hr each. Neither the incidence of phlebitis nor the degree of phlebitis was significantly different with the two drugs, and there was no difference in the time of onset of pain or phlebitis.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4597719      PMCID: PMC444404          DOI: 10.1128/AAC.3.2.306

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Clinical and in vitro evaluation of cephapirin: a new parenteral cephalosporin.

Authors:  S J Bodner; M G Koenig
Journal:  Am J Med Sci       Date:  1972-01       Impact factor: 2.378

2.  Evaluation of a new cephalosporin antibiotic, cephapirin.

Authors:  P Wiesner; R MacGregor; D Bear; S Berman; K Holmes; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

3.  Laboratory and pharmacologic studies of BL-P-1322 (cephapirin sodium) in children.

Authors:  R C Gordon; F F Barrett; D J Clark; M D Yow
Journal:  Curr Ther Res Clin Exp       Date:  1971-06

4.  Clinical and in vitro evaluation of cephapirin, a new cephalosporin antibiotic.

Authors:  J L Bran; M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

5.  Relative incidence of phlebitis caused by continuous intravenous infusion of cephapirin and cephalothin.

Authors:  A Z Lane; J G Taggart; R L Iles
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

  5 in total
  9 in total

1.  Comparison of phlebitis produced by cephapirin and cephalothin.

Authors:  A S Cross; E C Tramont
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

2.  Comparative incidence of phlebitis due to buffered cephalothin, cephapirin, and cefamandole.

Authors:  S Berger; E C Ernst; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

Review 3.  Newer beta-lactam antibiotics.

Authors:  J M Hamilton-Miller; W Brumfitt
Journal:  Infection       Date:  1974       Impact factor: 3.553

4.  Treatment of pneumonia and other serious bacterial infections with cephapirin.

Authors:  H G Robson; M I Bowmer
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

5.  Comparison of thrombophlebitis associated with three cephalosporin antibiotics.

Authors:  W T Siebert; E L Westerman; J D Smilack; M W Bradshaw; T W Williams
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

6.  [An investigation into the influence of human serum on the in-vitro activity of various cephalosporins (author's transl)].

Authors:  R Ratschow; J R Krone
Journal:  Infection       Date:  1977       Impact factor: 3.553

7.  Double-blind comparison of phlebitis produced by cephalothin infusions with buffered and unbuffered diluents.

Authors:  J Carrizosa; M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

8.  Bacampicillin, Ampicillin, Cephalothin, and Cephapirin levels in human blood and interstitial fluid.

Authors:  J S Tan; S J Salstrom
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

Review 9.  The cephalosporins: activity and clinical use.

Authors:  A J Weinstein
Journal:  Drugs       Date:  1980-08       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.